10-Year-Childhood Malignancy Profile Province-Wide in Indonesia
(2009-2018): Yogyakarta Pediatric Cancer Registry
Abstract
Background: In 2001, Dr. Sardjito Hospital initiated a
systematic hospital-based registry, Yogyakarta Pediatric Cancer Registry
(YPCR). This study aims to present an epidemiological profile of
childhood malignancies diagnosed in Dr. Sardjito General Hospital and
compare it with the previous study 1 Methods:
Childhood cancer was diagnosed in children aged 0-18 years, from January
2009 to December 2018, and analyzed. Childhood malignancies were
categorized based on age, sex, and disease group according to the
International Classification of Childhood Cancer (ICCC-3). An estimated
annual average incidence rate (AAIR) of childhood cancer was calculated.
We visualized the number of patients and their regions of origin by
geographic mapping. Result: There were 1,788 new cases
registered in YPCR during the study period. Of these, 58% were male,
with a male-to-female.4:1.0. The mean age at diagnosis was 6.3 years
old, the median age was 5 years and 56% of cancers were diagnosed in
the age group of 0-5 years old. The most common diagnosis category was
leukemia (ICCC-3 Category I), which accounted for 60% of all childhood
malignancies. The three most common diagnoses included: ALL (44%), AML
(13%), and retinoblastoma (6%). Of the 1,077 patients diagnosed with
leukemia, 58% were males, most often diagnosed at 0-5 years old (53%).
There were 679 patients registered with solid tumors mostly diagnosed at
0-5 years old (57%). The AAIR of leukemia and solid tumors was 26.8 and
17.5 per million, respectively. Conclusion: There was an
increase in the number of childhood malignancies in 2009-2018 compared
to the 2000-2009 study. The number of patients referred to our hospital
increased, indicating a better referral system to the pediatric cancer
center. This study is expected to provide data on the hospital-based
pediatric cancer registry in Indonesia and promote systematic pediatric
cancer registries in other centers.